Compare

Yubo International Biotech Ltd vs ADM Tronics Unlimited, Inc. vs Neuraxis, Inc vs Nuwellis, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearYubo International Biotech Ltd
YBGJ
ADM Tronics Unlimited, Inc.
ADMT
Neuraxis, Inc
NRXS
Nuwellis, Inc.
NUWE
Year ended2025-12-312026-03-312025-12-312025-12-31
Revenue$12.4K$3.35M$3.57M$8.27M
Revenue growth (YoY)+256.0%+4.7%+32.9%-5.4%
Gross margin66.1%40.5%84.2%62.0%
Operating marginn/m-4.8%-219.4%-134.3%
Net marginn/m-3.0%-218.5%-211.9%
Net income-$1.08M-$100.4K-$7.80M-$17.52M
EPS (Diluted)-$0.01$0.00-$0.95-$25.39
Operating cash flow-$842.8K-$124.1K-$6.43M-$10.81M
Free cash flown/an/a-$6.46M-$10.90M
Cash & equivalents$8.1K$255.7K$4.97M$1.08M
Total assets$847.1K$1.83M$6.40M$6.12M
Total liabilities$2.79M$1.26M$3.00M$3.49M
Shareholders' equity-$1.95M$571.0K$3.40M$2.62M
Return on year-end equityn/a-17.6%-229.5%-667.7%
Shares outstandingn/a67.59M10.65M1.69M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearYubo International Biotech LtdADM Tronics Unlimited, Inc.Neuraxis, IncNuwellis, Inc.
Latest$12.4K
Ended 2025-12-31
$3.35M
Ended 2026-03-31
$3.57M
Ended 2025-12-31
$8.27M
Ended 2025-12-31
1 year earlier$3.5K
Ended 2024-12-31
$3.20M
Ended 2025-03-31
$2.69M
Ended 2024-12-31
$8.74M
Ended 2024-12-31
2 years earlier$604.7K
Ended 2023-12-31
$2.97M
Ended 2024-03-31
$2.46M
Ended 2023-12-31
$8.86M
Ended 2023-12-31
3 years earlier$104.3K
Ended 2022-12-31
$3.68M
Ended 2023-03-31
$2.68M
Ended 2022-12-31
$8.54M
Ended 2022-12-31
4 years earlier$1.24M
Ended 2021-12-31
$3.21M
Ended 2022-03-31
n/a$7.92M
Ended 2021-12-31